Keywords
How to Cite
Abstract
Psoriasis is a common multifactorial, immunoassociated disease. Approximately one-third of patients have the disease in a recurrent manner and have a moderate or severe course. In addition to dermatological manifestations and lesions of the musculoskeletal system systemic manifestations and certain comorbid conditions are often observed in psoriasis: diabetes mellitus, hypertension, obesity and others. A patient with psoriasis falls into the professional field of interest of doctors in the following specialties: family doctor, dermatologist, rheumatologist, traumatologist, endocrinologist, cardiologist.
At the present phase of reforming of the health care system, in our opinion, the regulation of medical-diagnostic measures for GPs is especially relevant. The article presents in detail the route and management of a patient with psoriasis, psoriatic arthritis. Patients should be consulted annually by their GP, which includes documenting the severity of the disease using the DLQI scale, screening for depression, assessing cardiovascular risk, assessing joint symptoms, optimizing local therapy, evaluating the need for referral to a secondary care facility. Active intervention is needed to improve patients' quality of life and reduce the probability of psychosocial consequences.
The problem of psoriasis is an relevant medical, social and economic challenge in Ukraine. Undoubtedly, сonsidering the systemic nature of psoriatic disease and comorbidities, a personalized and multidisciplinary approach is required. Forehanded diagnostic, treatment measures, as well as collaborations with related professionals by family doctors determine the prognosis for the health and quality of life of a patients with psoriasis.
References
Global report on psoriasis. WHO 2016. Retrieved from WHO website: http://apps.who.int/iris/bitstream/10665/204417/1/9789241565189_eng.pdf
Psoriaz, vkliuchaiuchy psoriatychnu artropatiiu: adaptovana klinichna nastanova, zasnovana na dokazakh (Psoriasis, including psoriatic arthropathy: an adapted, evidence-based clinical setting). (2015). Kyiv, 223.
Psoriaz, vkliuchaiuchy psoriatychnu artropatiiu: unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy [Psoriasis, including psoriatic arthropathy: unified clinical protocol of primary, secondary (specialized), tertiary (highly specialized) medical care] (2015). Kyiv, 54.
Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry psoriazi, vkliuchaiuchy psoriatychni artropatii: Nakaz MOZ Ukrainy vid 20.11.2015 № 762 [Ministry of Health of Ukraine Order No. 762 of 20.11.2015 On approval and introduction of medical and technological documents on standardization of medical care for psoriasis, including psoriatic arthropathy].
International Classification of Diseases (ICD - 10). Available at: https://www.who.int/classifications/icd/icdonlineversions/en/
Sampogna F., Gisondi P., Melchi C. F. (2004). Prevalence of symptoms experienced by patients with different clinical types of psoriasis. Br J Dermatol., 151(3), 594–599.
Schafer I., Hacker J., Rustenbach S. J., Radtke M., Franzke N., Augustin M. (2010). Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. Eur J Dermatol., 20, 62–7.
Moll J. M., Wright V. (1973). Psoriatic arthritis. Semin Arthritis Rheum.,3(1), 55-78.
Stern R.S., Nijsten T., Feldman S.R., Margolis D.J., Rolstad T. (2004). Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc, 9(2), 136- 9.
Ibrahim G., Buch M., Lawson C., Waxman R., Helliwell P. S. (2009). Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol, 27(3), 469-74.
Mumtaz A., Gallagher P., Brian K. (2010). Development of Composite Psoriatic Disease Activity Index (CPDAI) in psoriatic arthritis. Irish Journal of Medical Science, 179, 546-547.
Daniel Pietrzak, Aldona Pietrzak (2017). Digestive system in psoriasis: an update. Arch Dermatol Res., 309(9), 679–693.
Bakulev A. L., Shagova Y. V., Kozlova I. V. (2008). Psoriaz kak sistemnaya patologiya [Psoriasis as a systemic pathology]. Saratov Journal of Medical Scientific Research, 4(1), 13-20.
Reich K. (2012). The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol., 26 Suppl 2, 3-11.
Hashim T., Ahmad A., Chaudry A., Khouzam R. (2017). Psoriasis and Cardiomyopathy: A Review of the Literature. South Med J., 110(2), 97-100.
Erythrodermic Psoriasis Causing Uric Acid Crystal Nephropathy (2019). Case Rep Med., 81. 658-08.
Takeshita J., Grewal S., Langan S.M. (2017). Psoriasis and comorbid diseases: Implications for management. J Am Acad Dermatol. Mar, 76(3), 393-403.
Danielsen K., Wilsgaard T., Olsen A.O. (2015). Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences. Br J Dermatol. 172, 419.
Gyldenlоve M., Storgaard H., Holst J. J. (2015). Patients with psoriasis are insulin resistant. J Am Acad Dermatol, 72, 599.
Lоnnberg A. S., Skov L., Skytthe A. (2016). Association of Psoriasis With the Risk for Type 2 Diabetes Mellitus and Obesity. JAMA Dermatol, 152, 761.
Snekvik I., Nilsen T. I. L., Romundstad P. R., Saunes M. (2019). Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway. Br J Dermatol., 180, 94.
Takeshita J., Wang S., Shin D. B. (2015). Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA Dermatol., 151, 161.
Association between psoriasis, psoriatic arthritis and gout: a nationwide population-based study. J Eur Acad Dermatol Venereol. 2019, 33(3), 560-567.
Chiesa Fuxench Z. C., Shin D. B., Ogdie Beatty A., Gelfand J. M. (2016). The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network. JAMA Dermatol, 152, 282.
Kimball A.B., Gladman D., Gelfand J. M. (2008). National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol, 58, 1031.
Cohen A. D., Dreiher J., Birkenfeld S. (2009). Psoriasis associated with ulcerative colitis and Crohn's disease. J Eur Acad Dermatol Venereol, 23, 561.
Kwok T., Jing Loo W., Guenther L. (2010). Psoriasis and multiple sclerosis: is there a link? J Cutan Med Surg., 14, 151.
Egeberg A., Mallbris L., Hilmar Gislason G. (2015). Increased risk of migraine in patients with psoriasis: A Danish nationwide cohort study. J Am Acad Dermatol., 73, 829.
Sheu J. J., Wang K. H., Lin H. C., Huang C. C. (2013). Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study. J Am Acad Dermatol., 68., 992.
Kathuria P., Gordon K. B., Silverberg J. I. (2017). Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fractures. J Am Acad Dermatol., 76, 1045.
Karaca S., Fidan F., Erkan F. (2013). Might psoriasis be a risk factor for obstructive sleep apnea syndrome? Sleep Breath., 17., 275.
He Z., Chen Y., Chen P. (2010). Local inflammation occurs before systemic inflammation in patients with COPD. Respirology., 15., 478.
Gupta M.A., Schork N. J., Gupta A.K. (1993). Suicidal ideation in psoriasis. Int J Dermatol., 32, 188.
Pearce D. J., Singh S., Balkrishnan R. (2006). The negative impact of psoriasis on the workplace. J Dermatolog Treat., 17, 24.
Cohen B. E., Martires K. J., Ho R. S. (2016). Psoriasis and the Risk of Depression in the US Population: National Health and Nutrition Examination Survey 2009-2012. JAMA Dermatol., 152, 73.
Tsyvilna asotsiatsiia “Vseukrainska patsiientska asotsiatsiia psoriazu“ [Civil Association “Ukrainian Patient’s Association of Psoriasis”]. Available at : https://uap.ip.cv.ua/.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.